Large genome-wide association studies (GWAS) performed to identify risk factors for late-onset AD (LOAD) revealed that genes encoding complement receptor CR1 (CR1) and the regulator clusterin (CLU) were among the significant hits (139, 140). The gene discussed is CLU; the disease is Alzheimer disease.